Navigation Links
Cord Blood America CEO and Co-Founder Matthew Schissler Named Chairman of Biotech Committee for Nevada Development Authority
Date:2/1/2011

LAS VEGAS, Feb. 1, 2011 /PRNewswire/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) (www.cordblood-america.com) has announced that Cord Blood America's CEO and Co-Founder Matthew Schissler has been named chairman of the Biotech Committee for the Nevada Development Authority.  The Biotech Committee is charged with developing programs and initiatives to help attract new biotech businesses to Southern Nevada and help existing biotech companies expand in the area.

"I am honored to be named chairman of the Biotech Committee for the Nevada Development Authority  and look forward to working with the committee to help attract new biotech businesses and expand existing ones in Southern Nevada," said Mr. Schissler.

He added, "Moving Cord Blood America to Southern Nevada 18 months ago was one of the best decisions in our history.  Nevada is extremely business friendly through low tax rates, laws and regulations.  Access to one of the busiest airports in the country, ease of getting around with little traffic or infrastructure issues, and the low cost of real estate and living were the key decision points for us.  Couple those with world-class accommodations, entertainment, millions of people attending conventions, and more than 20 percent of the top 100-rated restaurants in the country being on The Strip, and you have a recipe for an unsurpassed business environment.  I look forward to delivering this message to the thousands of domestic and international biotechs looking for a place to call home."

Somer Hollingsworth, president and CEO of the NDA, said Mr. Schissler is an asset to the NDA and will serve as a strong ambassador for the biotech and related industries.

"Now more than ever is a crucial time in Nevada's history to become increasingly proactive in attracting new businesses to our state," Mr. Hollingsworth said. "The biotech sector is a natural fit for Nevada, and we are relishing the fact that companies like Cord Blood America are realizing the advantages Nevada has to offer and are stepping up efforts to be a voice for our state."

About Cord Blood AmericaCord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of diseases, including cancer, leukemia, blood and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit www.corcell.com. For investor information, visit www.cordblood-america.com.

About Nevada Development AuthorityThe Nevada Development Authority is a non-profit agency that works to diversify and improve the economy of Southern Nevada. Established in Las Vegas in 1956, the NDA is dedicated to fostering an attractive, business-friendly environment through building key relationships while assisting and targeting new and expanding businesses.  The mission of the NDA is to attract, retain and expand the business base and enhance the overall socioeconomic development of Southern Nevada. CONTACT:Paul KnopickE & E Communications949/707-5365pknopick@eandecommunications.com
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
2. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
3. Limbs saved by menstrual blood stem cells
4. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
5. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
6. No Blood Needed Thanks to Innovative Medical Technology
7. The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System
8. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
9. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
10. American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC
11. China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xian Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
Breaking Biology News(10 mins):